Evidence map›Paper›PMID 28458909›Full record

ArticleEndocrinology, diabetes & metabolism case reports2017

Novel germline variant of

Kohei Saitoh, Takako Yonemoto, Takeshi Usui, Kazuhiro Takekoshi, Makoto Suzuki, Yoshiharu Nakashima, Koji Yoshimura, Rieko Kosugi, Tatsuo Ogawa, Tatsuhide Inoue

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Endocrinology, diabetes & metabolism case reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Kohei SaitohDepartments of Diabetes and Endocrinology.
Takako YonemotoDepartments of Diabetes and Endocrinology.
Takeshi UsuiMedical Genetics, Shizuoka General Hospital, ShizuokaJapan.
Kazuhiro TakekoshiDivision of Sports Science, Faculty of Medicine, University of Tsukuba, TsukubaJapan.
Makoto SuzukiDepartments of Pathology.
Yoshiharu NakashimaDepartments of Urology, Shizuoka General Hospital, ShizuokaJapan.
Koji YoshimuraDepartments of Urology, Shizuoka General Hospital, ShizuokaJapan.
Rieko KosugiDepartments of Diabetes and Endocrinology.
Tatsuo OgawaDepartments of Diabetes and Endocrinology.
Tatsuhide InoueDepartments of Diabetes and Endocrinology.
Diabetes Australia · AUShizuoka General Hospital · JPUniversity of Tsukuba · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

summaryPheochromocytomas (PCCs) and paragangliomas (PGLs) are rare tumours with a heterogeneous genetic background. Up to 40% of apparently sporadic PCC/PGL cases carry 1 of the 12 gene germline mutations conferring genetic susceptibility to PCC/PGL. Although the precise mechanisms are unclear, LEARNING POINTS: c.119C > T (p.S40F) is a novel

Identifiers

PMID28458909
PMCPMC5404711
OpenAlexW2604652858

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.